10.3390/jcm12134295 85
GLP-1 medicines are powerful prescription treatments for obesity and type 2 diabetes, with large trials behind them and side effects that warrant medical supervision
While GLP-1 and GIP receptor activation primarily reduce energy intake through appetite suppression and delayed gastric emptying, glucagon receptor activation continues to drive energy expenditure through thermogenesis and hepatic fat oxidation regardless of whether caloric intake has already decreased
Whatever the reason, changing your injection day is straightforward if you follow the rules
By engaging all three pathways at once, it offers researchers a tool for studying multi-receptor metabolic signalling in ways that single-agonist compounds cannot
Monitoring & adjustment : Periodic labs (micronutrients, metabolic markers, lean mass, bone density if relevant), and adjust supplements as needed under provider supervision